Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer.

Liu, Zhe; Parveen, Neha; Rehman, Urushi; Aziz, Aisha; Sheikh, Afsana; Abourehab, Mohammed A S; Guo, Wei; Huang, Junhao; Wang, Zhenning; Kesharwani, Prashant

Liu, Zhe; Parveen, Neha; Rehman, Urushi; Aziz, Aisha; Sheikh, Afsana; Abourehab, Mohammed A S; Guo, Wei; Huang, Junhao; Wang, Zhenning; Kesharwani, Prashant.

Afiliação

Liu Z; Department of Pancreatic-Biliary Surgery, The First Hospital of China Medical University, Shenyang, China.
Parveen N; Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.
Rehman U; Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.
Aziz A; Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.
Sheikh A; Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.
Abourehab MAS; Department of Pharmaceutics, College of Pharmacy, Umm Al-Qura University, Makkah, 21955, Saudi Arabia.
Guo W; Department of Pancreatic-Biliary Surgery, The First Hospital of China Medical University, Shenyang, China.
Huang J; Department of Pancreatic-Biliary Surgery, The First Hospital of China Medical University, Shenyang, China.
Wang Z; Department of Surgical Oncology and General Surgery, The First Hospital of China Medical University, 155N. Nanjing Street, Shenyang, 110001, Liaoning, China. znwang@cmu.edu.cn.
Kesharwani P; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical University, Shenyang, 110122, Liaoning, China. znwang@cmu.edu.cn.

Mol Cancer ; 22(1): 8, 2023 01 12.

Article em En | MEDLINE | ID: mdl-36635659

Assuntos

Antineoplásicos; Aptâmeros de Nucleotídeos; Neoplasias Pancreáticas; Humanos; RNA Interferente Pequeno/genética; Antineoplásicos/uso terapêutico; Qualidade de Vida; Aptâmeros de Nucleotídeos/genética; Aptâmeros de Nucleotídeos/uso terapêutico; Aptâmeros de Nucleotídeos/química; Recidiva Local de Neoplasia/tratamento farmacológico; Neoplasias Pancreáticas/terapia; Neoplasias Pancreáticas/tratamento farmacológico; Neoplasias Pancreáticas

Palavras-chave

Aptamers; Chemotherapeutic; Combination therapy; Nanoparticles; Pancreatic cancer; siRNA

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Aptâmeros de Nucleotídeos / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google